Personalized Dosimetry using 131I-anti-CD45-Apamistamab (Iomab-B) Prior to High-dose Myeloablative Radioimmunotherapy for Hematopoietic Stem Cell Transplant (HCT) in Active, Relapsed, or Refractory Acute Myelogenous Leukemia: Novel Re-induction and Targeted Conditioning Feasibility and Engraftment Results from the SIERRA Trial

Landis Griffeth; Susan Passalaqua; Gregory Wiseman; Norbert Avril; Wendell Yap; Ming-Kai Chen; Robert Wagner; Mona Natwa; Beth Chasen; Dominick Lamonica; Sandy Konerth; Darrell Fisher; Farnoush Safavi; Mark Berger; Vijay Reddy; Neeta Pandit-Taskar

Meeting ReportOncology: Clinical Therapy and Diagnosis

Personalized Dosimetry using ¹³¹I-anti-CD45-Apamistamab (Iomab-B) Prior to High-dose Myeloablative Radioimmunotherapy for Hematopoietic Stem Cell Transplant (HCT) in Active, Relapsed, or Refractory Acute Myelogenous Leukemia: Novel Re-induction and Targeted Conditioning Feasibility and Engraftment Results from the SIERRA Trial

Landis Griffeth, Susan Passalaqua, Gregory Wiseman, Norbert Avril, Wendell Yap, Ming-Kai Chen, Robert Wagner, Mona Natwa, Beth Chasen, Dominick Lamonica, Sandy Konerth, Darrell Fisher, Farnoush Safavi, Mark Berger, Vijay Reddy and Neeta Pandit-Taskar

Journal of Nuclear Medicine May 2019, 60 (supplement 1) 434;

Landis Griffeth

5Baylor University Medical Center Dallas TX United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Susan Passalaqua

4Banner MD Anderson Cancer Center Gilbert AZ United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Gregory Wiseman

7Mayo Clinic Rochester Rochester MN United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Norbert Avril

12University Hospital Cleveland Cleveland OH United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Wendell Yap

13University of Kansas Medical Center Kansas City KS United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Ming-Kai Chen

15Yale New Haven Hospital New Haven CT United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Robert Wagner

6Loyola University Medical Center Maywood IL United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mona Natwa

10Ohio State University Medical Center Cleveland OH United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Beth Chasen

8MD Anderson Cancer Center Bellaire TX United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Dominick Lamonica

11Roswell Park Cancer Institute Buffalo NY United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Sandy Konerth

14Versant Physics Kalamazoo MI United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Darrell Fisher

1Richland WA United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Farnoush Safavi

2Actinium Pharmaceuticals New York NY United States

3Actinium Pharmaceuticals New York NY United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Mark Berger

2Actinium Pharmaceuticals New York NY United States

3Actinium Pharmaceuticals New York NY United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Vijay Reddy

2Actinium Pharmaceuticals New York NY United States

3Actinium Pharmaceuticals New York NY United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Neeta Pandit-Taskar

9Memorial Sloan Kettering Cancer Center New York NY United States

Find this author on Google Scholar
Find this author on PubMed
Search for this author on this site

Article
Figures & Data
Info & Metrics

Article Figures & Data

Figures

Download figure
Open in new tab
Download powerpoint
Download figure
Open in new tab
Download powerpoint

In this issue

Journal of Nuclear Medicine

Vol. 60, Issue supplement 1

May 1, 2019

Table of Contents
Index by author

Article Alerts

User Name *

Password *

Email *

Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Your Email *

Your Name *

Send To *

Enter multiple addresses on separate lines or separate them with commas.

You are going to email the following Personalized Dosimetry using 131I-anti-CD45-Apamistamab (Iomab-B) Prior to High-dose Myeloablative Radioimmunotherapy for Hematopoietic Stem Cell Transplant (HCT) in Active, Relapsed, or Refractory Acute Myelogenous Leukemia: Novel Re-induction and Targe…

Message Subject (Your Name) has sent you a message from Journal of Nuclear Medicine

Message Body (Your Name) thought you would like to see the Journal of Nuclear Medicine web site.

Your Personal Message

Citation Tools

Personalized Dosimetry using ¹³¹I-anti-CD45-Apamistamab (Iomab-B) Prior to High-dose Myeloablative Radioimmunotherapy for Hematopoietic Stem Cell Transplant (HCT) in Active, Relapsed, or Refractory Acute Myelogenous Leukemia: Novel Re-induction and Targeted Conditioning Feasibility and Engraftment Results from the SIERRA Trial

Journal of Nuclear Medicine May 2019, 60 (supplement 1) 434;

Citation Manager Formats

BibTeX
Bookends
EasyBib
EndNote (tagged)
EndNote 8 (xml)
Medlars
Mendeley
Papers
RefWorks Tagged
Ref Manager
RIS
Zotero

Journal of Nuclear Medicine May 2019, 60 (supplement 1) 434;

Share This Article:

Tweet Widget
Facebook Like
Google Plus One

Bookmark this article

User Name *

Password *

Remember my user name & password.

Jump to section

Article
Figures & Data
Info & Metrics

No related articles found.

Google Scholar

Cited By...

No citing articles found.

Google Scholar

Oncology: Clinical Therapy and Diagnosis

Added value of single photon emission computed tomography (SPECT) / Computed Tomography (CT) with radioiodine whole body scan in follow up of patients with differentiated thyroid cancer
Assessment of semi-quantitative evaluation using SUV applying 2 phase-imaging of IMP SPECT for diagnosis of choroidal melanoma.
Surveillance Imaging of Laryngeal Cancer - Does FDG PET/CT Impact Survival?

Show more Oncology: Clinical Therapy and Diagnosis

Other Solid Tumors/ Hematologic Malignancies (Clinical) I

Analysis on the efficacy and influencing factors of 131I ablation of residual thyroid tissue in patients with thyroid papillary carcinoma
Favorable outcome of patients treated by radioembolization of liver metastasis from uveal melanoma

Show more Other Solid Tumors/ Hematologic Malignancies (Clinical) I

Main menu

User menu

Search

Article Figures & Data

Figures

In this issue

Citation Manager Formats

Related Articles

Cited By...

More in this TOC Section

Oncology: Clinical Therapy and Diagnosis

Other Solid Tumors/ Hematologic Malignancies (Clinical) I

Similar Articles